Federated Hermes, Inc. Applied Genetic Technologies Corp Transaction History

Federated Hermes, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.62 - $1.1 $75 - $134	-122 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.07 - $2.71 $1,920 - $4,864	-1,795 Reduced 93.64%	122 $1,000
Q4 2021 Feb 14, 2022	BUY	$1.87 - $2.91 $3,584 - $5,578	1,917 New	1,917 $4,000
Q4 2019 Feb 14, 2020	SELL	$2.69 - $4.92 $1,299 - $2,376	-483 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.59 - $4.16 $2,833 - $4,551	-1,094 Reduced 69.37%	483 $2,000
Q4 2018 Feb 13, 2019	BUY	$2.28 - $7.15 $3,595 - $11,275	1,577 New	1,577 $3,000
Q1 2018 May 09, 2018	SELL	$3.65 - $5.2 $3,942 - $5,616	-1,080 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$3.55 - $5.25 $3,834 - $5,670	1,080	1,080 $4,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.